Gregory George Adds To Mesoblast Position With Multi-Market Share Purchases
Mesoblast (ASX:MSB) Is Down 11.0% After FDA Clears Registrational DMD Trial For Ryoncil - Has The Bull Case Changed?
Is Mesoblast (ASX:MSB) Price Swings Creating A Possible Valuation Opportunity?
Mesabi Trust: Logistics Could Favor U.S. Iron Ore Supply
Mesabi Trust Press Release
MSB Global Group Berhad (KLSE:MSB) Shares Could Be 48% Below Their Intrinsic Value Estimate
Mesabi Trust: Arbitration Upside Vs. Operational Reality
Mesabi: Fiscal Q3 Earnings Snapshot
Mesabi: Fiscal Q2 Earnings Snapshot
Mesabi Trust: Attractive Yield, But Macro Headwinds Loom
Boasting A 21% Return On Equity, Is MSB Global Group Berhad (KLSE:MSB) A Top Quality Stock?
Estimating The Fair Value Of MSB Global Group Berhad (KLSE:MSB)
Mesabi: Fiscal Q1 Earnings Snapshot
Mesabi Trust (MSB): Among the Cheap Growth Stocks to Buy Now
Mesabi Trust (MSB): A Bull Case Theory
Reminder - Mesabi Trust (MSB) Goes Ex-Dividend Soon
Mesoblast management to meet with Maxim
Mesabi Trust raises quarterly distribution to 39c per share from 35c
Mesoblast Limited’s 2024 Annual Report Highlights Governance
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.